Laurent Genser
Overview
Explore the profile of Laurent Genser including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
98
Citations
1039
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dulac A, Torcivia A, Genser L
J Visc Surg
. 2025 Feb;
162(1):42-49.
PMID: 39904682
No abstract available.
2.
Baratte C, Sebbag H, Arnalsteen L, Auguste T, Blanchet M, Benchetrit S, et al.
J Visc Surg
. 2025 Jan;
162(1):71-78.
PMID: 39794164
IS ESG EFFECTIVE IN THE TREATMENT OF OBESITY AND ASSOCIATEDCOMORBIDITIES?: Endoscopic Sleeve Gastroplasty (ESG) is more effective than lifestyle modifications alone for weight loss and improving obesity-related comorbidities. While it...
3.
Pais R, Chouik Y, Moga L, Lebedel L, Silvain C, Genser L, et al.
Obes Surg
. 2024 Dec;
35(2):395-405.
PMID: 39739182
Background: In cirrhotic patients, portal hypertension increases mortality after surgery. We evaluated the impact of pre-operative transjugular intrahepatic portosystemic shunt (TIPS) on the outcomes of bariatric surgery in cirrhosis. Methods:...
4.
Steinbach E, Belda E, Alili R, Adriouch S, Dauriat C, Donatelli G, et al.
Gut Microbes
. 2024 Dec;
16(1):2405547.
PMID: 39679619
The intestinal microbiota is increasingly recognized as a crucial player in the development and maintenance of various chronic conditions, including obesity and associated metabolic diseases. While most research focuses on...
5.
Zambon Azevedo V, Bel Lassen P, Aron-Wisnewsky J, Genser L, Charlotte F, Bedossa P, et al.
Clin Nutr
. 2024 Nov;
43(12):254-264.
PMID: 39536396
Background & Aims: Sarcopenic obesity (SO) is associated with cardiometabolic disorders and steatotic liver disease and carries major health risks. We assessed the hepatic and metabolic clinical phenotype associated with...
6.
Bel Lassen P, Bedock D, Duong Vinh J, Arzouk N, Galichon P, Tourret J, et al.
Diabetes Obes Metab
. 2024 Oct;
27(1):438-441.
PMID: 39467059
No abstract available.
7.
Denis J, Boissan M, Rouzaud E, Lacorte J, Pocard M, Genser L
Ann Biol Clin (Paris)
. 2024 Aug;
82(3):321-328.
PMID: 39115286
CA 19-9 (carbohydrate antigen 19-9) is a tumor marker widely used for the follow-up of patients with pancreatic cancer and other digestive neoplasia. This case report describes a discrepancy between...
8.
Lecot-Connan T, Jeannin A, Baptiste A, Dechartres A, Genser L, Oppert J, et al.
Obes Surg
. 2024 Jun;
34(7):2305-2314.
PMID: 38842761
Purpose: The risks carried by pregnancy after bariatric surgery (BS) include small-for-gestational age (SGA) newborn and prematurity. However, the underlying mechanisms are not yet fully understood in pregnant women after...
9.
Thibaut F, Veziant J, Warlaumont M, Gauthier V, Lefevre J, Gronnier C, et al.
Eur J Surg Oncol
. 2024 Apr;
50(6):108310.
PMID: 38598874
Background: Although several prognostic factors in GIST have been well studied such as tumour size, mitotic rate, or localization, the influence of microscopic margins or R1 resection remains controversial. The...
10.